Navigation Links
IRIDEX Announces James Mackaness Will Be Chief Financial Officer
Date:12/17/2007

MOUNTAIN VIEW, Calif., Dec. 17 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that James H. Mackaness, 44, will join the Company as Chief Financial Officer effective January 2, 2008.

Mr. Mackaness is currently Chief Financial Officer and Vice President of Finance for NextHop Technologies, Inc., a networking wireless technology company. Previously, he served as Vice President of Finance and Chief Financial Officer for InfoGear Technology Corp., a company that developed and manufactured managed Internet appliances. While at InfoGear, Mr. Mackaness assisted with the sale of the company to Cisco Systems where he held a senior management position responsible for Business Development. Prior to his position at InfoGear, he served as Assistant Controller at Electroglas Inc., a manufacturer of inspection equipment for the semiconductor industry. Before Electroglas, Mr. Mackaness spent seven years at Ernst & Young where he advanced to the position of Audit Manager.

Mr. Mackaness, a Chartered Accountant and member of the Institute of Chartered Accountants of England and Wales, received his Bachelor of Arts degree in psychology from the University of Warwick, England.

"Jim will be a great addition to IRIDEX," commented Theodore A. Boutacoff, President & CEO. "He will provide a good balance of solid accounting & financial controls expertise with an understanding of what is required to optimize operational performance. As part of a transition plan, Jim will spend time at IRIDEX prior to his start date and will continue to provide support to NextHop during the first quarter of 2008."

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposab
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)... Calif., Nov. 6 Calbiotech, Inc. a...siness Innovative Research (SBIR) Phase I contract...mmand. Under terms of the agreement, Calbiotech wi...e diagnosis of Dengue virus. ,, Dengue virus...ajor threat to military forces deployed to tropica...
(Date:11/5/2009)...Md., Nov. 5 GenVec, Inc....sults for the third quarter ended September 30, 20....04 per share) for the three months ended Septembe...($0.08 per share) in the comparable quarter of 200...enVec,s net loss was $14.1 million ($0.15 per shar...
(Date:11/5/2009)...l on Thursday, November 5, 2009 at 4:30 p.m. Easte...RNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... ) today reported unaudited financial results for ...30, 2009 and reviewed the Company,s highlights for...nsolidated results reflect the operations of OncoG...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...ident and CEO of the University of Wisconsin Medic...irs for UW Medical School was the kick-off speaker...s interview with WTN, Dr. Grossman discusses how a... data but, at the same time a Knowledge Gap betwee...rd certified in internal medicine, pulmonary disea...
...hnology Network sat down with Tom Still, the presi...cuss the basic tenets of the organization and init... Wisconsins technology space grow. Read Part One. ...biggest challenges the Wisconsin Technology Counci...plishments? , ,Tom Still: The greatest accomplish...
...it is in chains. Fail to develop the talents of an...ury wealth. This quotation is taken from Tony Blai...K, in 1999. It opens chapter one of The Mismanagem...tive forthcoming book by British HR researchers An... ,The main focus of their research was on how univ...
Other Biology Technology:WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 2WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 4WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 5WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 2WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 3WTN exclusive interview with Tom Still, Wisconsin Technology Council - Part 2 4Talent Mismanagement 2Talent Mismanagement 3
(Date:11/6/2009)... To celebrate the 150th anniversary this month of ...merican Institute of Biological Sciences (AIBS) is... about Charles Darwin and his historic insights in...ian of the University of California, Berkeley, and...dian,s article, "Ten Myths About Charles Darwin," ...
(Date:11/6/2009)... PHILADELPHIA (November 06, 2009) The Monell Cent...o-hosts of the Beijing International Meeting on Ta...laboration with the CAS, the meeting will be the f...e held in China. , Alan Leshner, Chief Executive... of Science and Executive Publisher of Science mag...
(Date:11/5/2009)... Kent State University has been awarded a training... Science Foundation under its Integrative Graduati.... This is the first IGERT grant to be awarded to K...erican Recovery and Reinvestment Act of 2009, runs...t that focuses on environment aquatic resource sen...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Hospira Names Daphne E Jones Chief Information Officer 5611 1Hospira Names Daphne E Jones Chief Information Officer 5611 2Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 1Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 2Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 1Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 2
...with separate sexes, embryos commit to becoming ma...cision is made by sex determination genes on the s...lopment have changed remarkably little during evol...nd the sex chromosomes themselves are among the mo...research team formed by Sander van Doorn (Santa Fe...
...ional team of Australian and Israeli researchers h...e biggest moonlight sex event on Earth., An ancien...chers from the ARC Centre of Excellence for Coral ...gger for the annual mass spawning of corals across...ias Great Barrier Reef, shortly after a full moon....
... in mice of immune cells that promote the formatio...s for endometriosis, a painful condition associate...f women of reproductive age. , The formation of ...courage the growth of tumors and endometriosis les...arch associate in the Vascular Biology Program at ...
Other Biology News:A new explanation for evolutionary changes in genetic sex-determination systems 2Key found to moonlight romance 2Key found to moonlight romance 3Immune cells promote blood vessel formation in mouse endometriosis 2
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Essential Techniques: Gel Electrophoresis: Proteins from Promega
Colloids and Interfaces with Surfactants and Polymers an Introduction. Jim Goodwin. Wiley (2004); 296 pages soft cover from Invitrogen
Biology Products: